CDMO

The Improvements of the Production and Stability of a mAb-Chelator Conjugate by Modified Transchelation Conditions

Hyung-il Lee, Ph.D.

GBI

AI

AI Implementation to Enhance Quality

Seongil Cho; Hyeokgeon Kwon; Kisung Shim

Samsung Biologics

CDMO

Advancing the Science of Technical and Therapeutic Proteins

Eva-Karin Gidlund, Ph.D.

NorthX Biologics

AAV Quality

Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation

Nathan Sweeney, Ph.D.; Hena Divanovic, M.Sc.

Rentschler Biopharma SE

PPQ

Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months

Jessica Feldman, Ph.D.; Henning Gerschewski

Rentschler Biopharma SE

Lyophilization

Enhancing Biopharmaceutical Stability Through Lyophilization

David King; Hoju Lee; Sungjin Park; Yeonju Yoon

Samsung Biologics

Precision Medicine

Advancing Personalized Medicines and Precision Therapeutics

Thermo Fisher Scientific

Biotherapeutics

Building on Australia's Existing Biopharma Infrastructure

BIoCina

CDMO

Supporting Oral Solid Development in Australia and Beyond

Grant Swart

Mayne Pharma Services

Clinical Trials

One of Our First Looks at the Burgeoning Australia Biotech Ecosystem

PCI Pharma Services

QbD

Designing Quality into Biomanufacturing

Miguel Carrion; Michelle Kneeland

Tanvex CDMO

Advanced Therapies

A New Vision for Progressing Advanced Therapies

Nathaniel Youndt

ReciBioPharm

Lyophilization

Pioneering Innovation in Pharmaceutical Lyophilization

Thermo Fisher Scientific